Ing Groep Nv Cyma Bay Therapeutics, Inc. Transaction History

Ing Groep Nv

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$5.12 - $7.21 $742,400 - $1.05 Million	-145,000 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$6.05 - $13.66 $345,261 - $779,548	57,068 Added 64.9%	145,000 $1.04 Million
Q1 2019 May 13, 2019	SELL	$8.16 - $13.42 $240,720 - $395,890	-29,500 Reduced 25.12%	87,932 $1.17 Million
Q4 2018 Feb 13, 2019	BUY	$6.54 - $11.74 $768,005 - $1.38 Million	117,432 New	117,432 $924,000

1.88M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

Stay updated on Ing Groep Nv with notifications on news.